-
Posted by
Two Blokes Jul 8 -
Filed in
Stock
-
6 views
New publication in Nature Genetics using Parsortix identifies CTC clusters as promising targets to stop the spread of cancer GUILDFORD, SURREY / ACCESS Newswire / July 8, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of a peer-reviewed article in Nature Genetics by Professor Nicola Aceto's team at ETH Zurich, Switzerland. The study utilised the Parsortix\u00ae system to investigate the genetic diversity of CTC clusters.
